Characterisation of the Antibody Response in Sinopharm (BBIBP-CorV) Recipients and COVID-19 Convalescent Sera from the Republic of Moldova

The early availability of effective vaccines against SARS-CoV-2, the aetiologic cause of COVID-19, has been at the cornerstone of the global recovery from the pandemic. This study aimed to assess the antispike RBD IgG antibody titres and neutralisation potential of COVID-19 convalescent plasma and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ulinici, Mariana, Suljič, Alen, Poggianella, Monica, Milan Bonotto, Rafaela, Resman Rus, Katarina, Paraschiv, Angela, Bonetti, Amedeo Marco, Todiras, Mihail, Corlateanu, Alexandru, Groppa, Stanislav, Ceban, Emil, Petrovec, Miroslav, Marcello, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053079/
https://www.ncbi.nlm.nih.gov/pubmed/36992221
http://dx.doi.org/10.3390/vaccines11030637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053079/
https://www.ncbi.nlm.nih.gov/pubmed/36992221
http://dx.doi.org/10.3390/vaccines11030637

Ejemplares similares